NCT04552275 - The HALT Biomarker Study | Biotech Hunter

Enrollment

300

Participants

Timeline

Start Date

June 22, 2020

Primary Completion Date

June 22, 2030

Study Completion Date

June 22, 2035

Conditions

Aortic StenosisHypo-attenuated Leaflet ThickeningBioprosthetic Valve Degeneration

Interventions

DIAGNOSTIC_TEST

Proteomics Analysis

Determine a panel of circulating proteins that discriminates between patients with and without Hypo-Attenuated Leaflet Thickening (HALT)

Trial Locations (3)

NOT_YET_RECRUITING

Minneapolis Heart Institute, Minneapolis

RECRUITING

Massachusetts General Hospital, Boston

RECRUITING

Catholic Medical Center, Manchester